Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Quality Improvement in Pediatric Endocrinology fields
Release Date:
Partner: The Japanese Society for Pediatric Endocrinology
Review Process: Expert Review Panel
Quality Improvement Rare Disease Japan
Topical Hemostasis in Minimally Invasive Surgery
Release Date:
Review Process: Pfizer Internal
Education Hospital USA
Advances in Immuno-Oncology Therapy in Urothelial Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
IBD Fellow Training in US
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Integration of Biomarker Testing into Treatment Planning for Metastatic Colorectal Cancer
Release Date:
Partner: ACCC
Review Process: Expert Review Panel
Quality Improvement Oncology USA
Imaging Diagnostics for Differentiating Cardiac Amyloidosis
Release Date:
Review Process: Pfizer Internal
Education Rare Disease Japan
Telemedicine Initiatives for Patients with Suspected Cardiomyopathy of Unknown Cause
Release Date:
Review Process: Pfizer Internal
Education Rare Disease Japan
Improving Treatment Environment for Chronic Myeloid Leukemia (CML)
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Atrial Fibrillation and Venous Thromboembolism (excluding United States)
Release Date:
Partner: BMS
Review Process: Pfizer Internal
Education Internal Medicine All
Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology France, Germany, Italy, Japan, Spain, United Kingdom
China Breast Cancer Landscape – Educational Needs Assessment
Release Date:
Review Process: Pfizer Internal
Education Oncology China